Mon, Sep 07 · 9:00

Advanced Therapies is Europe’s most important advanced therapies conference and exhibition.

The event brings 300 expert speakers and 2,000 cell and gene professionals from biotech, pharma, payers, regulators, start-ups, investors, researchers and tech companies together. The agenda is organised around 12 tracks of exciting content, including:

- cell therapy

- immunotherapy

- pricing and market access

- manufacturing and bioprocess

- clinical trials

- rare diseases

- cord blood

- gene editing

- regenerative medicing

- pitch and partner

- end to end logistics

- gene therapy

The event covers each stage of development of cell, gene and immunotherapy - from bioprocessing through clinical translation to reimbursement, market access and delivery to patient.

For an updated speaker list, please visit:
To check the programme, please visit:
To book your ticket, please visit:


Standard Package 3 Days: GBP 2200.0
Academic Package 3 Days: GBP 595.0
Start Up Package 3 Days: GBP 1095.0
Standard Package 2 Days: GBP 1695.0
Academic Package 2 Days: GBP 425.0
Start Up Package 2 Days: GBP 850.0

Speakers: Martin Pule; SVP; Founder and CSO and Clinical Senior Lecturer; Haematology; Autolus and UCL Cancer Institute; Prasad Adusumilli; Attending Surgeon; Memorial Sloan Kettering Cancer Center; Pascal Touchon; President; Chief Executive Officer and Board Member; Atara Biotherapeutics; Federico Mingozzi; CSO; Spark Therapeutics; Christina Coughlin; Chief Medical Officer; Tmunity Therapeutics; Steve Kanner; CSO; Caribou Biosciences; Bradley Campbell; President and Chief Operating Officer; Amicus Therapeutics; Adrian Woolfson; Head of RandD; Sangamo Therapeutics; Fred Chereau; President and CEO; LogicBio Therapeutics; Christopher R. Heery; CMO; Precision BioSciences; Joanne Kurtzberg; Professor of Pediatrics and Pathology; Director; Marcus Center for Cellular Cures; Duke University Medical Center